CDK4 and neoplasm: Noticeably, two other classes of anti-tumor agents, i.e., CDK4/6 inhibitors [41] and DNA-demethylating agents [27], cause viral-mimicry in models of mammary cancer, suggesting a potential role of the CDK and DNA-demethylation pathways in the anti-proliferative effects triggered by ATRA.